Published in Radiother Oncol on February 01, 1997
Functional analysis of cyclin-dependent kinase inhibitors of Arabidopsis. Plant Cell (2001) 4.62
Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst (2000) 4.15
Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst (2001) 2.44
Is it necessary to repeat quality control procedures for head and neck patients? Radiother Oncol (1991) 1.93
Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. J Natl Cancer Inst Monogr (1992) 1.89
Breast conserving treatment of Paget's disease. Radiother Oncol (1990) 1.54
Is pulsed dose rate more damaging to spinal cord of rats than continuous low dose rate? Radiother Oncol (1997) 1.46
[100 years of radiology in the Netherlands. IX. Clinical radiobiology]. Ned Tijdschr Geneeskd (1995) 1.40
Vindesine-ifosfamide-platinum (VIP) induction chemotherapy in surgically staged IIIA-N2 non-small-cell lung cancer: a prospective study. Leuven Lung Cancer Group. Ann Oncol (1998) 1.38
Quality control of validity of data collected in clinical trials. EORTC Study Group on Data Management (SGDM). Eur J Cancer Clin Oncol (1989) 1.33
Locally advanced breast cancer: the contribution of cytotoxic and endocrine treatment to radiotherapy. An EORTC Breast Cancer Co-operative Group Trial (10792). Eur J Cancer Clin Oncol (1989) 1.30
Interobserver variations in gross tumor volume delineation of brain tumors on computed tomography and impact of magnetic resonance imaging. Radiother Oncol (2001) 1.26
Cosmetic evaluation of breast conserving treatment for mammary cancer. 1. Proposal of a quantitative scoring system. Radiother Oncol (1989) 1.25
Method for quantitative mapping of dynamic MRI contrast agent uptake in human tumors. J Magn Reson Imaging (2001) 1.25
Angiogenesis, hypoxia and VEGF expression during tumour growth in a human xenograft tumour model. Microvasc Res (2008) 1.15
Reirradiation of primary brain tumours: survival, clinical response and prognostic factors. Radiother Oncol (2001) 1.14
Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: a quantitative multi-parameter analysis. Int J Radiat Oncol Biol Phys (2000) 1.11
A "reappraisal" of the LQ model for the understanding of dose-fractionation in radiotherapy. Int J Radiat Oncol Biol Phys (1993) 1.09
Late effects of spinal cord irradiation with 300 kV X rays and 15 MeV neutrons. Br J Radiol (1974) 1.07
Application of an image analysis system to the quantitation of tumor perfusion and vascularity in human glioma xenografts. Microvasc Res (1995) 1.05
Cosmetic evaluation of breast conserving treatment for mammary cancer. 2. A quantitative analysis of the influence of radiation dose, fractionation schedules and surgical treatment techniques on cosmetic results. Radiother Oncol (1989) 1.05
Human errors in data transfer during the preparation and delivery of radiation treatment affecting the final result: "garbage in, garbage out". Radiother Oncol (1992) 1.04
The hypoxic tumour microenvironment, patient selection and hypoxia-modifying treatments. Clin Oncol (R Coll Radiol) (2007) 1.03
Tumor excision and radiotherapy as primary treatment of breast cancer. Analysis of patient and treatment parameters and local control. Radiother Oncol (1987) 1.03
Quality assessment of medical decision making in radiation oncology: variability in target volume delineation for brain tumours. Radiother Oncol (1993) 1.02
Acute reactions of the lip mucosa of mice to fractionated irradiations. Radiother Oncol (1984) 1.00
Effects of nicotinamide and carbogen on oxygenation in human tumor xenografts measured with luminescense based fiber-optic probes. Radiother Oncol (2000) 0.99
Vascularity and perfusion of human gliomas xenografted in the athymic nude mouse. Br J Cancer (1995) 0.99
Hypoxia in a human intracerebral glioma model. J Neurosurg (2000) 0.99
Radiation tolerance of the rat spinal cord: time-dose relationships. Radiology (1977) 0.97
A quantitative analysis of vascularization and perfusion of human glioma xenografts at different implantation sites. Microvasc Res (1999) 0.97
Pathophysiological mechanisms leading to the development of late radiation-induced damage to the central nervous system. Front Radiat Ther Oncol (1999) 0.96
Repopulation kinetics in irradiated mouse lip mucosa: the relative importance of treatment protraction and time distribution of irradiations. Radiat Res (1985) 0.95
Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas. Br J Cancer (2000) 0.95
Accelerated radiotherapy in glioblastoma multiforme: a dose searching prospective study. Radiother Oncol (1994) 0.93
Quantitation of angiogenesis in healing anastomoses of the rat colon. Exp Mol Pathol (1997) 0.93
Vascular perfusion and hypoxic areas in RIF-1 tumours after photodynamic therapy. Br J Cancer (1996) 0.92
Colonisation of Clostridium in the body is restricted to hypoxic and necrotic areas of tumours. Anaerobe (1998) 0.91
The EORTC treatment of early stages of Hodgkin's disease: the role of radiotherapy. Int J Radiat Oncol Biol Phys (1984) 0.91
Techniques for precision irradiation of the lateral half of the rat cervical spinal cord using 150 MeV protons [corrected]. Phys Med Biol (2001) 0.90
Radiation tolerance of rat spinal cord to pulsed dose rate (PDR-) brachytherapy: the impact of differences in temporal dose distribution. Radiother Oncol (2000) 0.89
Radiation-induced damage in the central nervous system: an interpretation of target cell responses. Br J Cancer Suppl (1986) 0.89
Changes of lymphocyte subsets after local irradiation for early stage breast cancer and seminoma testis: long-term increase of activated (HLA-DR+) T cells and decrease of "naive" (CD4-CD45R) T lymphocytes. Eur J Cancer (1992) 0.89
Clinical radiation doses for spinal cord: the 1998 international questionnaire. Radiother Oncol (2000) 0.89
Impact of the tumour bed effect on microenvironment, radiobiological hypoxia and the outcome of fractionated radiotherapy of human FaDu squamous-cell carcinoma growing in the nude mouse. Int J Radiat Biol (2001) 0.88
Noninvasive assessment of the functional neovasculature in 9L-glioma growing in rat brain by dynamic 1H magnetic resonance imaging of gadolinium uptake. J Cereb Blood Flow Metab (2000) 0.88
Multiparameter analysis of vasculature, perfusion and proliferation in human tumour xenografts. Br J Cancer (1998) 0.88
Constraints in the use of repair half times and mathematical modelling for the clinical application of HDR and PDR treatment schedules as an alternative for LDR brachytherapy. Radiother Oncol (1996) 0.88
Degenerative myelopathy in three strains of aging rats. Vet Pathol (1976) 0.87
Detection of liver metastases with superparamagnetic iron oxide in 15 patients: results of MR imaging at 1.5 T. AJR Am J Roentgenol (1989) 0.87
Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer. Radiother Oncol (1998) 0.87
Effect of X rays and neutrons on repair and regeneration in the rat spinal cord. Int J Radiat Oncol Biol Phys (1982) 0.87
Improved management of radiotherapy departments through accurate cost data. Radiother Oncol (2000) 0.87
Quality assurance in radiotherapy by in vivo dosimetry. 1. Entrance dose measurements, a reliable procedure. Radiother Oncol (1990) 0.87
Conventional radiotherapy combined with carbogen breathing and nicotinamide for malignant gliomas. Radiother Oncol (1995) 0.86
Repair kinetics as a determining factor for late tolerance of central nervous system to low dose rate irradiation. Radiother Oncol (1989) 0.86
Patterns of proliferation related to vasculature in human head-and-neck carcinomas before and after transplantation in nude mice. Int J Radiat Oncol Biol Phys (2001) 0.86
The programme of quality assurance of the EORTC radiotherapy group. A historical overview. Radiother Oncol (1993) 0.86
Characterization and validation of noninvasive oxygen tension measurements in human glioma xenografts by 19F-MR relaxometry. Int J Radiat Oncol Biol Phys (1999) 0.86
Effects of intrathecal methotrexate and cytosine arabinoside on the radiation tolerance of the rat spinal cord. Radiother Oncol (1985) 0.86
Thermal enhancement of the effectiveness of gamma radiation for induction of reproductive death in cultured mammalian cells. Int J Radiat Biol Relat Stud Phys Chem Med (1978) 0.85
Lack of evidence for increased tolerance of rat spinal cord with decreasing fraction doses below 2 Gy. Int J Radiat Oncol Biol Phys (1985) 0.85
Radiation-induced apoptosis of oligodendrocytes in vitro. Int J Radiat Biol (1992) 0.85
Chronic effects of neutrons and charged particles on spinal cord, lung, and rectum. Radiat Res Suppl (1985) 0.85
Characterisation of complete responders to combination chemotherapy for advanced breast cancer: a retrospective EORTC Breast Group study. Eur J Cancer (1996) 0.85
Does tumor control decrease by prolonging overall treatment time or interrupting treatment in laryngeal cancer? Radiother Oncol (1995) 0.85
Altered fractionation: limited by mucosal reactions? Radiother Oncol (1999) 0.84
Vascular architecture and microenvironmental parameters in human squamous cell carcinoma xenografts: effects of carbogen and nicotinamide. Radiother Oncol (1999) 0.84
Quality assurance in radiotherapy by in vivo dosimetry. 2. Determination of the target absorbed dose. Radiother Oncol (1990) 0.84
Radiotherapy with carbogen breathing and nicotinamide in head and neck cancer: feasibility and toxicity. Radiother Oncol (1995) 0.84
Continuous, hyperfractionated, accelerated radiotherapy (CHART) (by Dische and Saunders) Radiother Oncol (1989) 0.83
Antiangiogenic therapy in brain tumor models. J Neurooncol (1999) 0.83
Quality control of radiotherapy centres in Europe: beam calibration. Radiother Oncol (1994) 0.83
Kinetics of repair in the spinal cord of the rat. Radiother Oncol (1997) 0.82
Oxygen-sensitive enzyme-prodrug gene therapy for the eradication of radiation-resistant solid tumours. Gene Ther (2002) 0.82
Tolerance of rat spinal cord to continuous interstitial irradiation. Int J Radiat Oncol Biol Phys (1998) 0.82
Suramin treatment of human glioma xenografts; effects on tumor vasculature and oxygenation status. J Neurooncol (1999) 0.82
Reirradiation tolerance of the immature rat spinal cord. Radiother Oncol (1992) 0.82
Hormonal therapy prolongs survival in irradiated locally advanced breast cancer: a European Organization for Research and Treatment of Cancer Randomized Phase III Trial. J Clin Oncol (1997) 0.82
The kinetics of repair of sublethal damage in the rat cervical spinal cord during fractionated irradiations. Radiother Oncol (1984) 0.82
The EORTC randomized trial on three fractions per day and misonidazole (trial no. 22811) in advanced head and neck cancer: long-term results and side effects. Radiother Oncol (1995) 0.81
Radiation response of the rat cervical spinal cord after irradiation at different ages: tolerance, latency and pathology. Int J Radiat Oncol Biol Phys (1994) 0.81
Increased incidence of murine graft-versus-host disease after allogeneic bone marrow transplantation by previous infusion of syngeneic bone marrow cells. Transplantation (1984) 0.81
Clinical implications of incomplete repair parameters for rat spinal cord: the feasibility of large doses per fraction in PDR and HDR brachytherapy. Int J Radiat Oncol Biol Phys (2001) 0.81
Repair capacity of adult rat glial progenitor cells determined by an in vitro clonogenic assay after in vitro or in vivo fractionated irradiation. Int J Radiat Biol (1993) 0.81
Preliminary results of a quality assurance network for radiotherapy centres in Europe. Radiother Oncol (1993) 0.81
The feasibility of high-dose multiple daily fractionation and its combination with anoxic cell sensitizers in the treatment of head and neck cancer. A pilot study of the Radiotherapy Group of the EORTC (European Organisation for Research on Treatment of Cancer). Int J Radiat Oncol Biol Phys (1982) 0.80
Influence of combined use of nicotinamide and carbogen on rat spinal cord radiation tolerance. Radiother Oncol (1994) 0.80
Tangential breast irradiation: influence of technique of set-up on transfer errors and reproducibility. Radiother Oncol (1991) 0.80
Temporal sequence of early alterations in rat lung following thoracic X-irradiation. Int J Radiat Biol (1991) 0.80
The different clinical presentation, behaviour and prognosis of carcinomas originating in the epilarynx and the lower supraglottis. Radiother Oncol (1983) 0.80
Late radiation injuries of the gastrointestinal tract in the H2 and H5 EORTC Hodgkin's disease trials: emphasis on the role of exploratory laparotomy and fractionation. Radiother Oncol (1988) 0.79
Administration of nicotinamide during a five- to seven-week course of radiotherapy: pharmacokinetics, tolerance, and compliance. Radiother Oncol (1997) 0.79
Radiosensitivity of glial progenitor cells of the perinatal and adult rat optic nerve studied by an in vitro clonogenic assay. Radiother Oncol (1991) 0.79